Keywords: Europe, Biosimilars, Generic biotech APIs, Health spending, Pricing tactics, Europe, GBI Research

European governments' austerity pricing tactics support generic drug growth

Article | 09 July 2012

Government initiatives to cut health expenditure are likely to encourage sales of generic medications in Europe, according to a new ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in